Targeting one protein to treat two neurodegenerative diseases
Wednesday, April 12, 2017 - 15:31
in Health & Medicine
Disrupting production of ataxin-2 with antisense technology improves symptoms of ALS and spinocerebellar ataxia type 2 in mice